Orix Gives Private-Equity Fund for Life Sciences $150 Million Seed Capital

Orix USA Asset Management is providing $150 million in seed capital to two Fortress Investment Group LLC alumni for a private-equity fund focusing on health-care and life sciences companies.

The fund, run by New York-based New Health Capital Partners LLC, will invest in senior secured loans, majority equity stakes and other forms of structured financing, Orix said today in a statement.

Richard Baxter and Aron Dantzig, who founded New Health Capital last year, were most recently co-heads of Fortress’s health-care group, investing more than $1 billion since 2005. In exchange for the investment, Orix will take an undisclosed stake in the management company, said a person familiar with the matter, who asked not to be named because the fund is private.

“Partnering with Aron and Rich and their team gives Orix USA Asset Management a unique opportunity to invest in the health-care and life sciences sectors and further highlights our commitment to the global asset-management industry,” Michael Blum, president and chief executive, said in the statement.

Orix USA Asset Management, a unit of Tokyo-based Orix Corp., was formed last year after Orix bought most of Mariner Investment Group LLC, a hedge fund based in Harrison, New York.

Orix plans to make more investments, which may include everything from allocating capital to an existing fund in exchange for a share of its fee revenue to buying a majority stake in a money-management firm, Blum said in a telephone interview.

To contact the reporters on this story: Katherine Burton in New York at kburton@bloomberg.net; Bradley Keoun in New York at bkeoun@bloomberg.net

To contact the editors responsible for this story: Christian Baumgaertel at cbaumgaertel@bloomberg.net; Nick Heath at nheath2@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.